Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial.
Kenya KamimuraTakeshi SudaTakeshi YokooHiroteru KamimuraTsutomu KanefujiAtsunori TsuchiyaMasaaki TakamuraHirokazu KawaiNobuo WaguriSatoshi YamagiwaShuji TeraiPublished in: BMC cancer (2017)
This study was registered on 1 January 2012 with the University Hospital Medical Information Network Clinical Trials Registry ( http://www.umin.ac.jp/ctr/index.htm , UMIN000004691).